Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Texas Biotechnology presents integrin antagonists for alphavbeta1-mediated diseases

Nov. 9, 1999

Nasonex Nasal Spray approved in E.U. for use in young children

Nov. 8, 1999

In vivo bronchodilating, antiallergic effects documented for S-1319

Nov. 4, 1999

Bradykinin B2 antagonist active in a guinea pig model of allergic bronchitis

Nov. 4, 1999

Cytokine-inhibitory pyrazoles from Abbott: preparation, activity and use

Nov. 4, 1999

Millennium identifies key mediator of allergic immune response

Nov. 4, 1999

Shionogi describes wide series of sPLA2 inhibitors

Nov. 3, 1999

Dura begins clinical program on Budesonide Spiros

Oct. 29, 1999

Nortran's intractable cough treatment completes safety trial

Oct. 29, 1999

Dainippon Ink & Chemicals begins clinical testing of allergy drug

Oct. 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.